Company Filing History:
Years Active: 1998-2000
Title: Innovations of Mohamad Zaher Ahadi
Introduction
Mohamad Zaher Ahadi is a notable inventor based in Paterson, NJ (US). He has made significant contributions to the field of biomedical research, particularly in the development of innovative antibodies. With a total of 3 patents to his name, his work has the potential to impact various medical diagnostics and treatments.
Latest Patents
Ahadi's latest patents focus on monospecific antibodies against a subunit of fibrinogen. These inventions provide antibodies that are specifically reactive with the .alpha.E subunit of fibrinogen or its fragments, while not interacting with other portions of the fibrinogen molecule. The patents also include anti-.alpha.E probes, which consist of detectably labeled monospecific anti-.alpha.E antibodies. Furthermore, the inventions outline methods for using these antibodies to detect the .alpha.E subunit and its fragments, along with reagents and kits for performing these methods. The diagnostic methods developed can determine information related to atherogenesis, thrombogenesis, and pregnancy status or outcomes. Additionally, the inventions provide continuous cell lines that produce monospecific anti-.alpha.E antibodies.
Career Highlights
Ahadi is currently associated with the New York Blood Center, Inc., where he continues to advance his research and innovations. His work is crucial in the development of diagnostic tools that can enhance patient care and treatment outcomes.
Collaborations
Ahadi has collaborated with notable coworkers such as Gerd Grieninger and Yiping Fu. Their combined expertise contributes to the success of their research initiatives.
Conclusion
Mohamad Zaher Ahadi's contributions to the field of biomedical research through his innovative patents highlight his role as a significant inventor. His work in developing specific antibodies has the potential to revolutionize diagnostic methods and improve healthcare outcomes.